In the past number of years, the UK has witnessed a revolution in health-related body weight‑reduction treatment options — in the introduction of semaglutide (Wegovy®) into the increasing popularity of tirzepatide (Mounjaro®). Now, A different identify is drawing notice in both clinical and commu